You are here

  • Home
  • Archive
  • Volume 21, Issue 6
  • Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects

Article metrics

Article menu
Download PDFPDF
Aetiology/Harm
Cohort study
Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects

 

Online download statistics by month:

Online download statistics by month: September 2016 to March 2024

AbstractFullPdf
Sep 2016220109
Oct 201610378
Nov 20161751120
Dec 20161871568
Jan 2017135637
Feb 20172352
Mar 20173651
Apr 20174632
May 20172652
Jun 20173953
Jul 20173400
Aug 20174632
Sep 20175840
Oct 20174684
Nov 20176111
Dec 20175320
Jan 20188444
Feb 20185312
Mar 20187767
Apr 20187751
May 20187910
Jun 20184922
Jul 20185100
Aug 20183811
Sep 20183340
Oct 20185200
Nov 20187721
Dec 20189722
Jan 20197762
Feb 20197111
Mar 20194630
Apr 20192810
May 20193100
Jun 20191721
Jul 20194041
Aug 20192000
Sep 20193200
Oct 20192300
Nov 20193600
Dec 20192300
Jan 20203814
Feb 20202910
Mar 20202200
Apr 20201800
May 20204130
Jun 20203241
Jul 20202500
Aug 2020900
Sep 20203100
Oct 20201700
Nov 20201600
Dec 20201000
Jan 20212400
Feb 20211900
Mar 20211600
Apr 20211300
May 2021110
Sep 2021100
Oct 20212111
Nov 20212400
Dec 20214030
Jan 20222420
Feb 20222021
Mar 20222111
Apr 20222310
May 20224511
Jun 20224110
Jul 20222300
Aug 20225900
Sep 20225510
Oct 20225400
Nov 20224100
Dec 20221410
Jan 20231310
Feb 20235000
Mar 20232000
Apr 2023600
May 20231400
Jun 2023100
Jul 20231000
Aug 20231900
Sep 2023600
Oct 20231910
Nov 20233231
Dec 20236620
Jan 20241400
Feb 20242000
Mar 20243410
Total3690167194